| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.098 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |